CA
FRLN

CHI Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$373K Buy
86,654
+64,988
+300% +$279K 0.15% 25
2023
Q2
$55.9K Sell
21,666
-4,707,753
-100% -$12.1M 0.02% 25
2023
Q1
$2.15M Sell
4,729,419
-85,000
-2% -$38.7K 0.57% 19
2022
Q4
$2.29M Hold
4,814,419
0.61% 17
2022
Q3
$3.37M Sell
4,814,419
-47,900
-1% -$33.5K 0.91% 19
2022
Q2
$4.23M Hold
4,862,319
1.62% 13
2022
Q1
$5.45M Buy
4,862,319
+2,985,930
+159% +$3.34M 2.32% 9
2021
Q4
$3.72M Buy
1,876,389
+448,908
+31% +$889K 1.23% 16
2021
Q3
$4.87M Buy
1,427,481
+47,638
+3% +$162K 1.42% 13
2021
Q2
$11.2M Sell
1,379,843
-4,900
-0.4% -$39.9K 2.62% 11
2021
Q1
$17M Buy
1,384,743
+23,679
+2% +$291K 3.41% 11
2020
Q4
$24.9M Buy
1,361,064
+36,700
+3% +$670K 7% 6
2020
Q3
$20.7M Buy
+1,324,364
New +$20.7M 7.35% 6